The National Institutes of Health has appointed Diana Bianchi as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). She is expected to join the NIH on Oct. 31. Bianchi will join NICHD from the Floating Hospital for Children and Tufts Medical Center, where she serves as the founding executive director of the Mother Infant Research Institute and vice chair for pediatric research. She also serves as a professor of pediatrics, and obstetrics and gynecology at Tufts University School of Medicine, and as the editor-in-chief of the international journal Prenatal Diagnosis.
Chris Hodkinson, Marc van der Schee, and Hamilton Scanlon
Owlstone Medical has appointed Chris Hodkinson as vice president of business development, Marc van der Schee as lead clinical research scientist, and Hamilton Scanlon as vice president of manufacturing. Hodkinson joins Owlstone from Abcodia, which he co-founded and where he served as director and chief operating officer. Van der Schee joins the company with 10 years of experience in the field of volatile biomarker research. Scanlon joins Owlstone with over 30 years of experience in product development. He has worked at start-up companies and PLCs, and has been responsible for setting up manufacturing facilities within China, Italy, and the UK.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.